BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2855408)

  • 1. Receptor mediated leukemogenesis: murine leukemia virus interacts with BCL1 lymphoma cell surface IgM.
    McGrath MS; Tamura G; Weissman IL
    J Mol Cell Immunol; 1987; 3(4):227-42. PubMed ID: 2855408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
    Tamura GS; McGrath MS; Weissman IL
    J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
    Ciavarra RP; Vitetta ES; Forman J
    J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-1a cell origin of the murine B lymphoma line BCL1 characterized by surface markers and bacterial reactivity of its surface IgM.
    Koganei S; Ito M; Yamamoto K; Matsumoto N
    Immunol Lett; 2005 May; 98(2):232-44. PubMed ID: 15860223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
    George AJ; Tutt AL; Stevenson FK
    J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
    Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
    J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
    Brooks KH; Vitetta ES
    J Immunol; 1986 Nov; 137(10):3205-10. PubMed ID: 2945863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a spontaneous murine B cell leukemia (BCL1). I. Cell surface expression of IgM, IgD, Ia, and FcR.
    Knapp MR; Jones PP; Black SJ; Vitetta ES; Slavin S; Strober S
    J Immunol; 1979 Sep; 123(3):992-9. PubMed ID: 313960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody.
    Vitetta ES; Yuan D; Krolick K; Isakson P; Knapp M; Slavin S; Strober S
    J Immunol; 1979 May; 122(5):1649-54. PubMed ID: 109513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiotype vaccination leads to the emergence of a stable surface Ig-negative variant of the mouse lymphoma BCL1, with different growth characteristics.
    George AJ; Spellerberg MB; Stevenson FK
    J Immunol; 1988 Mar; 140(5):1695-701. PubMed ID: 3162250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of membrane and secreted immunoglobulin during the in vitro differentiation of the murine B cell lymphoma CH12.
    Stockdale AM; Dul JL; Wiest DL; Digel M; Argon Y
    J Immunol; 1987 Nov; 139(10):3527-35. PubMed ID: 3500220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of IgH V-region genes on the growth kinetics of a murine B cell leukemia (BCL1).
    Ciavarra R; Forman J
    J Immunol; 1981 Jan; 126(1):54-8. PubMed ID: 6778917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, distribution and specificity of Fc receptors for IgM on murine B cells.
    Mathur A; Lynch RG; Köhler G
    J Immunol; 1988 Sep; 141(6):1855-62. PubMed ID: 2971716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
    Henderson LA; Ciavarra R; Riblet R; Forman J
    J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells.
    King CA; Wills MR; Hamblin TJ; Stevenson FK
    Cell Immunol; 1993 Apr; 147(2):411-24. PubMed ID: 8095858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-induced murine B cell lymphomas. I. Induction and characterization of CH1 and CH2.
    Lynes MA; Lanier LL; Babcock GF; Wettstein PJ; Haughton G
    J Immunol; 1978 Dec; 121(6):2352-7. PubMed ID: 363945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic induction of malignant lymphoma: graft-vs-host reaction-induced B cell lymphomas contain integrations of predominantly ecotropic murine leukemia proviruses.
    Pals ST; Zijstra M; Radaszkiewicz T; Quint W; Cuypers HT; Schoenmakers HJ; Melief CJ; Berns A; Gleichmann E
    J Immunol; 1986 Jan; 136(1):331-9. PubMed ID: 2999247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation by the BCL1 murine B cell line: in vitro stimulation by LPS.
    Harris MR; Kindle CS; Abruzzini AF; Pierce CW; Cullen SE
    J Immunol; 1984 Sep; 133(3):1202-8. PubMed ID: 6611366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest.
    Santos-Argumedo L; Gordon J; Heath AW; Howard M
    Cell Immunol; 1994 Jul; 156(2):272-85. PubMed ID: 7517793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity.
    Arnold LW; LoCascio NJ; Lutz PM; Pennell CA; Klapper D; Haughton G
    J Immunol; 1983 Oct; 131(4):2064-8. PubMed ID: 6194226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.